Blog

1 October 2024 - The October 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

1 October 2024 - The October 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

24 September 2024 - PHARMAC is widening access to a medicine to treat urinary tract infections and funding a combination ...

18 September 2024 - PHARMAC is consulting on a proposal to fund the medicine lenvatinib mesylate for three types of cancer ...

9 September 2024 - PHARMAC has decided to widen access to two medicines for several types of cancer. ...

9 September 2024 - Australians with Fabry disease, a rare genetic condition, and people with kidney cancer now have access ...

The September 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

1 September 2024 - The September 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

26 August 2024 - Cigna said on Monday it will remove AbbVie’s rheumatoid arthritis drug Humira from some of its ...

28 August 2024 - Australians diagnosed with a type of metastatic breast cancer will now have access to a life ...

19 August 2024 - On 1 September 2024, migalastat hydrochloride (Galafold) will become available on the PBS for the treatment ...

12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines ...

1 August 2024 - Medison Pharma, alongside their partner Alnylam Pharmaceuticals, are pleased to announce that from 1 August 2024, ...

2 August 2024 - A groundbreaking pan-tumour pharmaceutical that can act upon multiple different tumour types has been publicly funded ...